Related Experiment Video
Updated: Jun 10, 2025

Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation
Published on: July 6, 2022
Biological functions of the m6A reader YTHDF2 and its role in central nervous system disorders
Lili Song1, Huimin Liu1, Weiyu Yang1
1School of Traditional Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, China.
Abstract:
N6-methyladenosine (m6A) is a prevalent mRNA modification in eukaryotic cells, characterized by its reversible nature. YTH structural domain family protein 2 (YTHDF2), a key reader of m6A, plays a crucial role in identifying and binding m6A-containing RNAs, thereby influencing RNA metabolism through various functional mechanisms. The upstream and downstream targets of YTHDF2 are critical in the pathogenesis of various central nervous system (CNS) diseases, affecting disease development by regulating signaling pathways and gene expression. This paper provides an overview of current research on the role of YTHDF2 in CNS diseases and investigates the regulatory mechanisms by which YTHDF2 influences the development of these conditions. This exploration aims to improve understanding of disease pathogenesis and offer novel insights for the targeted prevention and treatment of neurological disorders.
Insights
N6-methyladenosine (m6A) modification is regulated by YTHDF2, a key protein influencing RNA metabolism. YTHDF2
Area of Science:
- Molecular Biology
- Epigenetics
- Neuroscience
Background:
- N6-methyladenosine (m6A) is a prevalent, reversible mRNA modification in eukaryotes.
- YTH structural domain family protein 2 (YTHDF2) is a critical m6A reader, binding m6A-modified RNAs.
- YTHDF2 influences RNA metabolism and cellular functions through diverse mechanisms.
Purpose of the Study:
- To review the role of YTHDF2 in the pathogenesis of central nervous system (CNS) diseases.
- To investigate the regulatory mechanisms of YTHDF2 in neurological disorder development.
- To provide insights for targeted prevention and treatment of CNS diseases.
Main Methods:
- Literature review of current research on YTHDF2 and CNS diseases.
- Analysis of YTHDF2's upstream and downstream targets in disease pathogenesis.
- Exploration of YTHDF2's regulatory roles in signaling pathways and gene expression.
Main Results:
- YTHDF2 is implicated in the pathogenesis of various CNS diseases.
- YTHDF2 regulates key signaling pathways and gene expression relevant to neurological disorders.
- Understanding YTHDF2's targets is crucial for disease development.
Conclusions:
- YTHDF2 plays a significant role in the development and progression of CNS diseases.
- Targeting YTHDF2-mediated pathways offers potential therapeutic strategies for neurological disorders.
- Further research into YTHDF2's mechanisms can advance the prevention and treatment of CNS conditions.
Related Concept Videos
Neurotransmitters
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Master Transcription Regulators
The Blood-brain Barrier

